UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

The Journal of clinical investigation, 2005-12, Vol.115 (12), p.3623-3633

2005

Volltextzugriff (PDF)

Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer

Cancer research (Chicago, Ill.), 2000-10, Vol.60 (19), p.5522-5528

2000

Volltextzugriff (PDF)

Specific binding of HIV‐1 nucleocapsid protein to PSI RNA in vitro requires N‐terminal zinc finger and flanking basic amino acid residues

The EMBO journal, 1994-04, Vol.13 (7), p.1525-1533

1994

Volltextzugriff (PDF)

Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer

The Journal of immunology (1950), 2005-03, Vol.174 (6), p.3798-3807

2005

Volltextzugriff (PDF)

Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells

Cancer research (Chicago, Ill.), 2003-05, Vol.63 (9), p.2127-2133

2003

Volltextzugriff (PDF)

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

The Journal of clinical investigation, 2002-02, Vol.109 (3), p.409-417

2002

Volltextzugriff (PDF)

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

The Journal of clinical investigation, 2002-02, Vol.109 (3), p.409-417

2002

Volltextzugriff (PDF)

Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro

Journal of Virology, 1996-02, Vol.70 (2), p.771-777

1996

Volltextzugriff (PDF)

Injection of Immature Dendritic Cells into Adjuvant-Treated Skin Obviates the Need for Ex Vivo Maturation

The Journal of immunology (1950), 2003-12, Vol.171 (11), p.6275-6282

2003

Volltextzugriff (PDF)

Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro

Vaccine, 2003-03, Vol.21 (11), p.1250-1255

2003

Volltextzugriff (PDF)

Enhanced induction of telomerase-specific CD4+ T cells using dendritic cells transfected with RNA encoding a chimeric gene product

Cancer research (Chicago, Ill.), 2002-09, Vol.62 (17), p.5041-5048

2002

Volltextzugriff (PDF)

Induction of Human Dendritic Cell Maturation Using Transfection with RNA Encoding a Dominant Positive Toll-Like Receptor 4

The Journal of immunology (1950), 2004-06, Vol.172 (11), p.7162-7168

2004

Volltextzugriff (PDF)

Technology Insight: vaccine therapy for prostate cancer

Nature clinical practice urology, 2005-01, Vol.2 (1), p.44-51

2005

Volltextzugriff (PDF)

The polypurine tract, PPT, of HIV as target for antisense and triple-helix-forming oligonucleotides

Biochimie, 1993, Vol.75 (1), p.71-78

1993

Volltextzugriff (PDF)

Enhancement of antitumor immunity following depletion of CD4 + CD25 + regulatory T cells

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2506-2506

2004

Volltextzugriff (PDF)

Enhancement of antitumor immunity following depletion of CD4 + CD25 + regulatory T cells

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2506-2506

2004

Volltextzugriff (PDF)

Current Status of Dendritic Cell-Based Tumor Vaccination

Oncology research and treatment, 2000-12, Vol.23 (6), p.544-551

2000

Volltextzugriff (PDF)

Reversal of immature myeloid cell-mediated immunosuppression

Journal of clinical oncology, 2005-06, Vol.23 (16_suppl), p.2563-2563

2005

Volltextzugriff (PDF)

Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen

Cancer research (Chicago, Ill.), 1997-02, Vol.57 (3), p.495-499

1997

Volltextzugriff (PDF)

Development of gene therapy for prostate cancer using a novel promoter of prostate‐specific antigen

British Journal of Urology, 1997-03, Vol.79 (S1), p.97-103

1997

Volltextzugriff (PDF)

Tumor vaccines: from gene therapy to dendritic cells—the emerging frontier

Urologic Clinics of North America, 2003-08, Vol.30 (3), p.633-643

2003

Volltextzugriff (PDF)

Immature myeloid cell (ImC)- mediated immunosuppression in advanced renal cell cancer (RCC)

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.10042-10042

2006

Volltextzugriff (PDF)

Vaccination of metastatic prostate cancer patients using mature dendritic cells transfected with mRNA encoding hTERT or an MHC class II targeted hTERT/LAMP fusion protein: Results from a phase I clinical trial

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2507-2507

2004

Volltextzugriff (PDF)

Vaccination of metastatic prostate cancer patients using mature dendritic cells transfected with mRNA encoding hTERT or an MHC class II targeted hTERT/LAMP fusion protein: Results from a phase I clinical trial

Journal of clinical oncology, 2004-07, Vol.22 (14_suppl), p.2507-2507

2004

Volltextzugriff (PDF)

Cotransfection of DC with TLR4 and MART-1 RNA induces MART-1-specific responses

The Journal of surgical research, 2005-04, Vol.124 (2), p.264-273

2005

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(35)

Sprache

Englisch
(34)
Russisch
(1)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

Prostate stem cell antigen is a promising candidate for immunotherapy of advanced prostate cancer

Specific binding of HIV‐1 nucleocapsid protein to PSI RNA in vitro requires N‐terminal zinc finger and flanking basic amino acid residues

Telomerase mRNA-Transfected Dendritic Cells Stimulate Antigen-Specific CD8+ and CD4+ T Cell Responses in Patients with Metastatic Prostate Cancer

Immunological and clinical responses in metastatic renal cancer patients vaccinated with tumor RNA-transfected dendritic cells

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro

Injection of Immature Dendritic Cells into Adjuvant-Treated Skin Obviates the Need for Ex Vivo Maturation

Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro

Enhanced induction of telomerase-specific CD4+ T cells using dendritic cells transfected with RNA encoding a chimeric gene product

Induction of Human Dendritic Cell Maturation Using Transfection with RNA Encoding a Dominant Positive Toll-Like Receptor 4

Technology Insight: vaccine therapy for prostate cancer

The polypurine tract, PPT, of HIV as target for antisense and triple-helix-forming oligonucleotides

Enhancement of antitumor immunity following depletion of CD4 + CD25 + regulatory T cells

Enhancement of antitumor immunity following depletion of CD4 + CD25 + regulatory T cells

Current Status of Dendritic Cell-Based Tumor Vaccination

Reversal of immature myeloid cell-mediated immunosuppression

Identification of a positive regulatory element responsible for tissue-specific expression of prostate-specific antigen

Development of gene therapy for prostate cancer using a novel promoter of prostate‐specific antigen

Tumor vaccines: from gene therapy to dendritic cells—the emerging frontier

Immature myeloid cell (ImC)- mediated immunosuppression in advanced renal cell cancer (RCC)

Vaccination of metastatic prostate cancer patients using mature dendritic cells transfected with mRNA encoding hTERT or an MHC class II targeted hTERT/LAMP fusion protein: Results from a phase I clinical trial

Vaccination of metastatic prostate cancer patients using mature dendritic cells transfected with mRNA encoding hTERT or an MHC class II targeted hTERT/LAMP fusion protein: Results from a phase I clinical trial

Cotransfection of DC with TLR4 and MART-1 RNA induces MART-1-specific responses

Suchergebnisse filtern